Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0000950170-24-017237 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-20 | 2024-02-15 | KPTI | Poulton Stuart | EVP, Chief Development Off | S - Sale | $1.33 | -5,847 | 163.8K | -3% | -$7,783 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-15 | S | D | 5,748 | $1.33 | 163,871 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-15 | S | D | 99 | $1.40 | 163,772 | D | — | — |